PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25402373-5	2014	Treatment of human pancreatic BON1, bronchopulmonary NCI-H727, and midgut GOT1 neuroendocrine tumor cells with increasing concentrations of metformin (0.1-10 mM) dose-dependently suppressed cell viability and cell counts.	Metformin	140-149	glutamic-oxaloacetic transaminase 1	Homo sapiens	74-78	
30222970-8	2018	The gene expression of the metabolic regulator glutamic-oxaloacetic transaminase 1 decreased in wild type cells upon metformin treatment whereas there was a trend of increased expression in the siSLC25A10 cells upon metformin treatment.	Metformin	117-126	glutamic-oxaloacetic transaminase 1	Homo sapiens	47-82	
30222970-8	2018	The gene expression of the metabolic regulator glutamic-oxaloacetic transaminase 1 decreased in wild type cells upon metformin treatment whereas there was a trend of increased expression in the siSLC25A10 cells upon metformin treatment.	Metformin	216-225	glutamic-oxaloacetic transaminase 1	Homo sapiens	47-82	
25402373-6	2014	Metformin induced AMPK phosphorylation in pancreatic BON1 and midgut GOT1 but suppressed AMPK activity in bronchopulmonary NCI-H727.	Metformin	0-9	glutamic-oxaloacetic transaminase 1	Homo sapiens	69-73